Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California. Show more

Location: 701 Anacapa Street, Santa Barbara, CA, 93101, United States | Website: https://phytanix.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

1.135M

52 Wk Range

$0.26 - $14.28

Previous Close

$0.66

Open

$0.66

Volume

44,621

Day Range

$0.59 - $0.72

Enterprise Value

2.475M

Cash

2.722M

Avg Qtr Burn

N/A

Insider Ownership

3.59%

Institutional Own.

6.08%

Qtr Updated

09/30/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
PT00114 Details
Major depression, anxiety disorders, PTSD, addiction / substance use disorders

Phase 2

Initiation